Similarly, tumor surveillance guidelines for individuals with NF1 issued by the European Reference Network on Genetic Tumor Risk Syndromes (ERN GENTURIS) state that GIST surveillance should be performed based on the clinical suspicion of symptoms [18]. The gene discussed is NF1; the disease is gastrointestinal stromal tumor.